Clearbridge Investments, LLC Ionis Pharmaceuticals Inc Transaction History

Clearbridge Investments, LLC

$122 Billion
Q1 2024

A detailed history of Clearbridge Investments, LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Clearbridge Investments, LLC holds 4,466,191 shares of IONS stock, worth $213 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

4,466,191

Previous 4,707,480 5.13%

Holding current value

$213 Million

Previous $238 Million 18.7%

% of portfolio

0.16%

Previous 0.21%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$42.03 - $53.55 $10.1 Million - $12.9 Million	-241,289 Reduced 5.13%	4,466,191 $194 Million
Q4 2023 Feb 09, 2024	SELL	$43.39 - $51.63 $5.78 Million - $6.88 Million	-133,215 Reduced 2.75%	4,707,480 $238 Million
Q3 2023 Nov 13, 2023	SELL	$38.5 - $47.13 $13.3 Million - $16.3 Million	-346,509 Reduced 6.68%	4,840,695 $220 Million
Q2 2023 Aug 11, 2023	SELL	$34.73 - $43.33 $7.1 Million - $8.86 Million	-204,377 Reduced 3.79%	5,187,204 $213 Million
Q1 2023 May 12, 2023	SELL	$33.58 - $41.2 $1.14 Million - $1.4 Million	-34,061 Reduced 0.63%	5,391,581 $193 Million

Q4 2022 Feb 10, 2023	SELL	$37.12 - $46.52 $12.9 Million - $16.2 Million	-348,250 Reduced 6.03%	5,425,642 $205 Million
Q3 2022 Nov 14, 2022	SELL	$36.54 - $48.66 $8.47 Million - $11.3 Million	-231,926 Reduced 3.86%	5,773,892 $255 Million
Q2 2022 Aug 11, 2022	SELL	$31.71 - $43.0 $14.9 Million - $20.2 Million	-470,215 Reduced 7.26%	6,005,818 $222 Million
Q1 2022 May 13, 2022	BUY	$29.88 - $37.04 $17.7 Million - $22 Million	593,051 Added 10.08%	6,476,033 $240 Million
Q4 2021 Feb 11, 2022	SELL	$25.61 - $35.1 $37 Million - $50.7 Million	-1,444,340 Reduced 19.71%	5,882,982 $179 Million
Q3 2021 Nov 12, 2021	BUY	$33.54 - $40.55 $17.2 Million - $20.8 Million	511,721 Added 7.51%	7,327,322 $246 Million
Q2 2021 Aug 13, 2021	SELL	$34.54 - $47.25 $20.3 Million - $27.8 Million	-587,366 Reduced 7.93%	6,815,601 $272 Million
Q1 2021 May 13, 2021	BUY	$42.51 - $63.78 $20.7 Million - $31.1 Million	487,820 Added 7.05%	7,402,967 $333 Million
Q4 2020 Feb 10, 2021	SELL	$45.3 - $60.27 $16.2 Million - $21.6 Million	-358,218 Reduced 4.93%	6,915,147 $391 Million
Q3 2020 Nov 12, 2020	SELL	$47.45 - $62.95 $18.5 Million - $24.5 Million	-388,859 Reduced 5.08%	7,273,365 $345 Million
Q2 2020 Aug 14, 2020	SELL	$46.85 - $61.05 $17.4 Million - $22.7 Million	-372,040 Reduced 4.63%	7,662,224 $452 Million
Q1 2020 May 15, 2020	BUY	$41.6 - $63.4 $3.61 Million - $5.5 Million	86,688 Added 1.09%	8,034,264 $380 Million
Q4 2019 Feb 14, 2020	SELL	$53.85 - $65.27 $72.3 Million - $87.7 Million	-1,343,348 Reduced 14.46%	7,947,576 $484 Million
Q3 2019 Nov 14, 2019	SELL	$59.06 - $72.15 $12.5 Million - $15.2 Million	-211,108 Reduced 2.22%	9,290,924 $557 Million
Q2 2019 Aug 14, 2019	BUY	$62.09 - $86.14 $231,098 - $320,613	3,722 Added 0.04%	9,502,032 $0
Q1 2019 May 15, 2019	SELL	$52.92 - $81.17 $46.7 Million - $71.6 Million	-882,009 Reduced 8.5%	9,498,310 $771 Million
Q4 2018 Feb 14, 2019	BUY	$43.37 - $59.54 $6.22 Million - $8.54 Million	143,380 Added 1.4%	10,380,319 $561 Million
Q3 2018 Nov 14, 2018	SELL	$42.88 - $53.7 $25 Million - $31.3 Million	-583,181 Reduced 5.39%	10,236,939 $528 Million
Q2 2018 Aug 14, 2018	SELL	$40.53 - $50.7 $4.05 Million - $5.07 Million	-99,989 Reduced 0.92%	10,820,120 $451 Million
Q1 2018 May 15, 2018	SELL	$44.08 - $55.05 $2.85 Million - $3.56 Million	-64,709 Reduced 0.59%	10,920,109 $481 Million
Q4 2017 Feb 14, 2018	SELL	$50.3 - $64.39 $22.9 Million - $29.3 Million	-455,033 Reduced 3.98%	10,984,818 $553 Million
Q3 2017 Nov 14, 2017	SELL	$45.56 - $59.57 $17.7 Million - $23.1 Million	-388,030 Reduced 3.28%	11,439,851 $580 Million
Q2 2017 Aug 14, 2017	BUY	N/A	11,827,881	11,827,881 $602 Million

Others Institutions Holding IONS

# of Institutions

396

Shares Held

122M

Call Options Held

854K

Put Options Held

464K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $6.76B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearbridge Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearbridge Investments, LLC with notifications on news.

Account

Clearbridge Investments, LLC Ionis Pharmaceuticals Inc Transaction History